ACTION FOR PULMONARY FIBROSIS
APF raises awareness and understanding of pulmonary fibrosis with patients, families, the general public and the medical profession. We advocate for patients nationally to improve treatment and care. We support patients by assisting in setting up patient support groups, hold information events and by personal contact. We offer study sessions for health professionals and offer research grants.
Objects
THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH IN PARTICULAR BY:A) ADVANCING EDUCATION AND RAISING AWARENESS OF PULMONARY FIBROSIS, THE SYMPTOMS ASSOCIATED WITH IT AND ENCOURAGING EARLIER DIAGNOSIS OF THE CONDITION.B) PROMOTING RESEARCH INTO THE UNDERSTANDING, DIAGNOSIS, CAUSES AND TREATMENTS OF PULMONARY FIBROSIS THROUGH DONATIONS AND GRANTS TO RELATED RESEARCH PROJECTS IN ORDER THAT THE USEFUL RESULTS OF RESEARCH ARE DISSEMINATED FOR PUBLIC BENEFIT.C) PROVIDING SUPPORT TO PATIENTS AND FAMILIES SUFFERING FROM PULMONARY FIBROSIS IN ANY OTHER WAY THE TRUSTEES SEE FIT.
Financial health, per its FY2025 accounts
The charity reported a surplus of £207,302 for the year ended 30 June 2025, with total income of £1,991,368 and expenditure of £1,784,066. Free reserves stood at £539,560, which exceeds the trustees' policy target of £500,000. The accounts were prepared on a going concern basis with no material uncertainties identified by the auditors.
What the accounts disclose
“One employee earned between £70,000 and £80,000 during the year (2024: one employee earned between £70,000 and £80,000).” — page 46
“The Board of Trustees considers it prudent to maintain a level of free reserves that provides the charity with sufficient working capital to support its core fundraising, support and governance activities for a period of 3 months (£350,000), plus an additional £150,000 to meet any unexpected call on funds or opportunities that may present themselves at short notice. Having carefully considered the best interests of the charity and its beneficiaries, the Board of Trustees believes it appropriate to aim to hold a total of £500,000 free reserves.”
“Stephen Jones and Helen Parfrey, trustees of Action for Pulmonary Fibrosis (APF) and also board members of the European Idiopathic Pulmonary Fibrosis and related disorders Federation (EUIPFF). During the year, APF received income of £3,989 from EU-IPFF for speaker fees (2023/24: £2,628 for speaker fees).” — page 52
“APF received an aggregate value of £400 from one Trustee, with no conditions attached.”
“Stephen Jones and Helen Parfrey, trustees of Action for Pulmonary Fibrosis (APF) and also board members of the European Idiopathic Pulmonary Fibrosis and related disorders Federation (EUIPFF). During the year, APF received income of £3,989 from EU-IPFF for speaker fees (2023/24: £2,628 for speaker fees).” — page 52
“APF received an aggregate value of £400 from one Trustee, with no conditions attached.”
“Stephen Jones and Helen Parfrey, trustees of Action for Pulmonary Fibrosis (APF) and also board members of the European Idiopathic Pulmonary Fibrosis and related disorders Federation (EUIPFF). During the year, APF received income of £3,989 from EU-IPFF for speaker fees (2023/24: £2,628 for speaker fees).” — page 52
“APF received an aggregate value of £400 from one Trustee, with no conditions attached.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 30/06/2025
- Volunteers: 62
- Government income: £10,500 — grants £10,500 (1); under 1% of the £1,991,368 total gross income on the same return
- Employees paid over £60,000: 2 (£60,001–£70,000: 2)
Self-declared on the annual return for the financial year ending 30/06/2024
- Volunteers: 30
- Government income: £168,118 — grants £168,118 (1); 11% of the £1,485,083 total gross income on the same return
- Employees paid over £60,000: 1 (£70,001–£80,000: 1)
Self-declared on the annual return for the financial year ending 30/06/2023
- Volunteers: 100
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
Leadership, per the charity’s website
- Dr Michael Stubbins — Chair of Trustees
Structured financials (annual return, FY ending 30/06/2025)
Trustees
- Dr Michael James Stubbinschair
- Dr HELEN PARFREY
- Dr Simon Hart
- Emma Goodes
- Matthew Suddart
- Stephen Morgan-Hyland
- Wendy Anne Dickinson
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £2.0m | £1.8m |
| 30/06/2024 | £1.5m | £2.2m |
| 30/06/2023 | £1.4m | £1.2m |
| 30/06/2022 | £975k | £795k |
| 30/06/2021 | £652k | £601k |
Common questions
Is ACTION FOR PULMONARY FIBROSIS financially healthy?
Per its FY2025 accounts: The charity reported a surplus of £207,302 for the year ended 30 June 2025, with total income of £1,991,368 and expenditure of £1,784,066. Free reserves stood at £539,560, which exceeds the trustees' policy target of £500,000. The accounts were prepared on a going concern basis with no material uncertainties identified by the auditors. Its FY2025 accounts were audited by Godfrey Wilson Limited.
Who funds ACTION FOR PULMONARY FIBROSIS?
Funders whose own accounts filings name ACTION FOR PULMONARY FIBROSIS as a grant recipient include THE EDWARD CADBURY CHARITABLE TRUST, CHRISTOS LAZARI FOUNDATION, THE HISCOX FOUNDATION, THE WARWICKSHIRE MASONIC CHARITABLE ASSOCIATION LIMITED, CHAPMAN CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE EDWARD CADBURY CHARITABLE TRUST | FY2024 | £5k | Compassionate Support |
| THE EDWARD CADBURY CHARITABLE TRUST | FY2022 | £5k | Compassionate Support |
| CHRISTOS LAZARI FOUNDATION | FY2025 | £5k | Funding towards the research programme aiming at improving early diagnosis, developing effective treatments and improving understanding of the biological basis |
| THE HISCOX FOUNDATION | FY2024 | £4k | |
| THE WARWICKSHIRE MASONIC CHARITABLE ASSOCIATION LIMITED | FY2022 | £4k | |
| THE EDWARD CADBURY CHARITABLE TRUST | FY2023 | £3k | Compassionate Support |
| THE HISCOX FOUNDATION | FY2023 | £1k | |
| THE WARWICKSHIRE MASONIC CHARITABLE ASSOCIATION LIMITED | FY2023 | £1k | |
| CHAPMAN CHARITABLE TRUST | FY2023 | £1k | |
| THE WARWICKSHIRE MASONIC CHARITABLE ASSOCIATION LIMITED | FY2021 | £1k |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 28/11/2024 | £499k | Bringing the Pulmonary Fibrosis community together to increase support |
| The National Lottery Community Fund | 27/07/2021 | £490k | Connecting and empowering the pulmonary fibrosis community |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE THOMAS J HORNE MEMORIAL TRUST | 1 | £28k |
| PEACOCK CHARITABLE TRUST | 1 | £18k |
| THE ROGER & DOUGLAS TURNER CHARITABLE TRUST | 1 | £15k |
| THE THREE OAKS TRUST | 1 | £10k |
| THE CLARE MILNE TRUST | 1 | £5k |
| THE DIXIE ROSE FINDLAY CHARITABLE TRUST | 1 | £5k |
| THE HOSPITAL OF GILBERT, EARL OF SHREWSBURY AT SHEFFIELD | 1 | £2k |
| THE HILARY AWDRY CHARITABLE TRUST | 1 | £2k |
Charities like this
- PULMONARY FIBROSIS TRUST
- PULMONARY HYPERTENSION ASSOCIATION UK
- THE NEUROFIBROMATOSIS ASSOCIATION
- FREEMAN HEART & LUNG TRANSPLANT ASSOCIATION
- ASSOCIATION FOR RESPIRATORY TECHNOLOGY AND PHYSIOLOGY
- ATRIAL FIBRILLATION ASSOCIATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ACTION FOR PULMONARY FIBROSIS | £2.0m | — | 1 | above | — | no doubt |
| PULMONARY FIBROSIS TRUST | £345k | — | 0 | unclear | — | no doubt |
| PULMONARY HYPERTENSION ASSOCIATION UK | £782k | — | 0 | unclear | — | no doubt |
| THE NEUROFIBROMATOSIS ASSOCIATION | £555k | — | 0 | below | 24.1% | no doubt |
| FREEMAN HEART & LUNG TRANSPLANT ASSOCIATION | £148k | — | 0 | above | — | no doubt |
| ASSOCIATION FOR RESPIRATORY TECHNOLOGY AND PHYSIOLOGY | £796k | — | 0 | above | — | no doubt |